Cargando…
Three-month outcomes of recovered COVID-19 patients: prospective observational study
AIMS: A novel coronavirus SARS-CoV-2 has resulted in an ongoing global pandemic of Coronavirus disease 2019 (COVID-19). However, the outcomes of recovered patients have not been well defined. METHODS: This is a prospective observational follow-up study of survivors with COVID-19 from a designated te...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064514/ https://www.ncbi.nlm.nih.gov/pubmed/33878961 http://dx.doi.org/10.1177/17534666211009410 |
_version_ | 1783682151880851456 |
---|---|
author | Cao, Jie Zheng, Xueying Wei, Wei Chu, Xinmin Chen, Xianmeng Wang, Ying Liu, Qiqi Luo, Sihui Weng, Jianping Hu, Xiaowen |
author_facet | Cao, Jie Zheng, Xueying Wei, Wei Chu, Xinmin Chen, Xianmeng Wang, Ying Liu, Qiqi Luo, Sihui Weng, Jianping Hu, Xiaowen |
author_sort | Cao, Jie |
collection | PubMed |
description | AIMS: A novel coronavirus SARS-CoV-2 has resulted in an ongoing global pandemic of Coronavirus disease 2019 (COVID-19). However, the outcomes of recovered patients have not been well defined. METHODS: This is a prospective observational follow-up study of survivors with COVID-19 from a designated tertiary center in Hefei, China. We examined chest computed tomography (CT) scanning, pulmonary function, 6-min walk distance (6MWD), and 36 item Short Form General Health Survey (SF-36). RESULTS: Among 81 enrolled patients, 62 (77%) patients and 61 (75%) patients, respectively, completed 1-month and 3-month follow-ups. Abnormal CT findings were still present in 73% of patients at 1 month and 54% at 3 months, whereas chest CT scan scores improved progressively at 1-month (5.0 ± 5.1) and 3-month follow up (3.0 ± 4.5) compared with that during hospitalization (11 ± 6.8). Mild restrictive pulmonary impairment was detected in 11% and 10% of patients at 1-month and 3-month follow up, respectively. The 6MWD was 523 ± 77 m in male patients and 484 ± 58 m in female patients, which was significantly lower than in healthy controls (606 ± 68 m, 568 ± 78 m, p < 0.001). SF-36 scores were significantly impaired in the domains of role physical (RP), role emotional (RE), and social functioning (SF) compared with the normal age-matched population. RP was improved at 3-month compared with 1-month follow up in the 41–64 years group (p < 0.01). Multivariable analysis showed that older age (over 40 years) and steroid administration during hospitalization were independently associated with worse chest CT scores at 3-month follow up. CONCLUSIONS: At 3 months, chest CT abnormalities were present in one half of COVID-19 survivors and worse chest CT scores were independently associated with older age and steroid administration during hospitalization. Residual pulmonary function impairments were modest, whereas exercise capacity and SF-36 scores were significantly lower than the general population. Support program and further follow-up evaluations may be needed. The reviews of this paper are available via the supplemental material section. |
format | Online Article Text |
id | pubmed-8064514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-80645142021-05-05 Three-month outcomes of recovered COVID-19 patients: prospective observational study Cao, Jie Zheng, Xueying Wei, Wei Chu, Xinmin Chen, Xianmeng Wang, Ying Liu, Qiqi Luo, Sihui Weng, Jianping Hu, Xiaowen Ther Adv Respir Dis Original Research AIMS: A novel coronavirus SARS-CoV-2 has resulted in an ongoing global pandemic of Coronavirus disease 2019 (COVID-19). However, the outcomes of recovered patients have not been well defined. METHODS: This is a prospective observational follow-up study of survivors with COVID-19 from a designated tertiary center in Hefei, China. We examined chest computed tomography (CT) scanning, pulmonary function, 6-min walk distance (6MWD), and 36 item Short Form General Health Survey (SF-36). RESULTS: Among 81 enrolled patients, 62 (77%) patients and 61 (75%) patients, respectively, completed 1-month and 3-month follow-ups. Abnormal CT findings were still present in 73% of patients at 1 month and 54% at 3 months, whereas chest CT scan scores improved progressively at 1-month (5.0 ± 5.1) and 3-month follow up (3.0 ± 4.5) compared with that during hospitalization (11 ± 6.8). Mild restrictive pulmonary impairment was detected in 11% and 10% of patients at 1-month and 3-month follow up, respectively. The 6MWD was 523 ± 77 m in male patients and 484 ± 58 m in female patients, which was significantly lower than in healthy controls (606 ± 68 m, 568 ± 78 m, p < 0.001). SF-36 scores were significantly impaired in the domains of role physical (RP), role emotional (RE), and social functioning (SF) compared with the normal age-matched population. RP was improved at 3-month compared with 1-month follow up in the 41–64 years group (p < 0.01). Multivariable analysis showed that older age (over 40 years) and steroid administration during hospitalization were independently associated with worse chest CT scores at 3-month follow up. CONCLUSIONS: At 3 months, chest CT abnormalities were present in one half of COVID-19 survivors and worse chest CT scores were independently associated with older age and steroid administration during hospitalization. Residual pulmonary function impairments were modest, whereas exercise capacity and SF-36 scores were significantly lower than the general population. Support program and further follow-up evaluations may be needed. The reviews of this paper are available via the supplemental material section. SAGE Publications 2021-04-20 /pmc/articles/PMC8064514/ /pubmed/33878961 http://dx.doi.org/10.1177/17534666211009410 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Cao, Jie Zheng, Xueying Wei, Wei Chu, Xinmin Chen, Xianmeng Wang, Ying Liu, Qiqi Luo, Sihui Weng, Jianping Hu, Xiaowen Three-month outcomes of recovered COVID-19 patients: prospective observational study |
title | Three-month outcomes of recovered COVID-19 patients: prospective observational study |
title_full | Three-month outcomes of recovered COVID-19 patients: prospective observational study |
title_fullStr | Three-month outcomes of recovered COVID-19 patients: prospective observational study |
title_full_unstemmed | Three-month outcomes of recovered COVID-19 patients: prospective observational study |
title_short | Three-month outcomes of recovered COVID-19 patients: prospective observational study |
title_sort | three-month outcomes of recovered covid-19 patients: prospective observational study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064514/ https://www.ncbi.nlm.nih.gov/pubmed/33878961 http://dx.doi.org/10.1177/17534666211009410 |
work_keys_str_mv | AT caojie threemonthoutcomesofrecoveredcovid19patientsprospectiveobservationalstudy AT zhengxueying threemonthoutcomesofrecoveredcovid19patientsprospectiveobservationalstudy AT weiwei threemonthoutcomesofrecoveredcovid19patientsprospectiveobservationalstudy AT chuxinmin threemonthoutcomesofrecoveredcovid19patientsprospectiveobservationalstudy AT chenxianmeng threemonthoutcomesofrecoveredcovid19patientsprospectiveobservationalstudy AT wangying threemonthoutcomesofrecoveredcovid19patientsprospectiveobservationalstudy AT liuqiqi threemonthoutcomesofrecoveredcovid19patientsprospectiveobservationalstudy AT luosihui threemonthoutcomesofrecoveredcovid19patientsprospectiveobservationalstudy AT wengjianping threemonthoutcomesofrecoveredcovid19patientsprospectiveobservationalstudy AT huxiaowen threemonthoutcomesofrecoveredcovid19patientsprospectiveobservationalstudy |